Bringing the fundamentals into focus…
Back to Lyell Immunopharma, Inc.
How Lyell Immunopharma, Inc. stacks up
LYEL · against 327 other Healthcare companies of similar size
Profitability
2/ 100
Near the bottom of its peers.
Ranked #322 of 328 · scores higher than 2% of peers
Bars: peers in each 10-point band of the profitability score43 peers with a profitability score of 0–9, including LYEL · Click a bar to see the companies
Why profitability scores 2?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 100% of peers. Operating margin: -949981.5% vs peer median 7.1%
- a lower return on assets: weaker than 97% of peers. Return on assets: -79.9% vs peer median 1.7%
- a lower return on invested capital: weaker than 94% of peers. Return on invested capital: -126.0% vs peer median 4.7%
Metric by metric
Position: dot = LYEL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LYEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 290 reported | -126.0% | -0.5% | 7% | 33% | |
| Operating marginHigher is better · 307 reported | -949981.5% | 2.1% | 0% | 33% | |
| Return on assetsHigher is better · 328 reported | -79.9% | -0.4% | 4% | 33% | |
| Return on equityHigher is better · 307 reported | -93.3% | -0.7% | 8% | Context only | |
| Gross marginHigher is better · 344 reported | 100.0% | 37.3% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around LYEL| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 5.5B NOK (≈$523M) | 98 | 71 | |
| 2 | 261M USD | 98 | 97 | |
| 4 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 4 | 356M AUD (≈$235M) | 97 | 81 | |
| 318 | 35.2B JPY (≈$240M) | 3 | 12 | |
| 318 | 454M AUD (≈$299M) | 3 | 7 | |
| 318 | 184M USD | 3 | 33 | |
| 318 | 186M USD | 3 | 52 | |
| 322 | 264M USD | 2 | 24 | |
| 323 | 149M USD | 1 | 10 | |
| 323 | 427M USD | 1 | 7 | |
| 323 | 258M USD | 1 | ||
| 323 | 140M USD | 1 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score